JAMA Editors' Summary Semaglutide for Weight Loss, Ivermectin for Mild COVID-19, USPSTF Guideline on Screening for Vitamin D Deficiency, and more
Apr 13, 2021
Exploring the results of two trials on Semaglutide for weight management. Results show its effectiveness in weight loss and improvements in health. Clinical trials on Semaglutide and Ivermectin for mild COVID-19 symptoms. Discussion on Ivermectin use, Vitamin D deficiency screening, and COVID-19 vaccine questions.
Chapters
Transcript
Episode notes
1 2 3 4
Introduction
00:00 • 2min
Effects of Samaglutide for Weight Loss: Clinical Trials and Weight Loss Maintenance
02:29 • 3min
Clinical Trials on Semaglutide for Weight Loss and Ivermectin for Mild COVID-19
05:47 • 2min
Ivermectin for Mild COVID-19, Vitamin D Deficiency Screening, Healthcare Reform, and COVID-19 Vaccine Questions
07:43 • 3min